Wells Fargo Initiates Coverage on the Pharmaceutical Space - Enact Holdings (NASDAQ:ACT)

Wells Fargo initiated coverage on the pharmaceutical space.

Outperform Initiations

Wells Fargo initiated coverage on Actavis ACT with a Outperform rating. Shares are up more that 0.757 percent at $208.96 Wednesday morning.
The firm initiated coverage on Endo Health Solutions Inc. ENDP with a Outperform rating. Shares closed at $68.20 on Monday and are trending lower. The stock is currently trading at $67.87.
The analyst initiated coverage on Jazz Pharmaceuticals plc JAZZ with a Outperform rating. Shares have climbed as much as 0.686 percent.
Wells Fargo initiated coverage on Mylan Inc. MYL with a Outperform rating. The stock fell 0.84 percent before regaining losses.

Market Perform Initiations

Wells Fargo initiated coverage on Teva Pharmaceutical Industries Limited TEVA with a Market Perform rating. The stock has traded as high as 0.69% at $52.36 Wednesday morning.
The analyst initiated coverage on Hospira Inc HSP with a Market Perform rating. Shares are up as much as 1.576 percent at $52.84.
The firm initiated coverage on Impax Laboratories, Inc. IPXL with a Market Perform rating. The stock is trading lower, down as much as 3 percent on Wednesday morning.

SLXP